<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="41945">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02013024</url>
  </required_header>
  <id_info>
    <org_study_id>S53410</org_study_id>
    <nct_id>NCT02013024</nct_id>
  </id_info>
  <brief_title>The Effect of Vitrification Versus Slow Freezing on Day 3: a Randomised Controlled Trial.</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sophie Debrock</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Katholieke Universiteit Leuven</source>
  <oversight_info>
    <authority>Belgium: The Federal Public Service (FPS) Health, Food Chain Safety and Environment</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized controlled trial (RCT) testing the hypothesis that vitrification is superior to
      slow freezing.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Life birth rate per embryo thawed</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>live birth rate per embryo transferred</measure>
    <time_frame>3</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>survival rate</measure>
    <time_frame>3 year</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>implantation rate per embryo transferred</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>implantation rate per embryo thawed</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>abortion rate</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Cryopreservation of Embryos</condition>
  <arm_group>
    <arm_group_label>cryopreservation technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>slow freezing cryopreservation technique</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vitrification cryopreservation technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>vitrification cryopreservation technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>cryopreservation technique</intervention_name>
    <arm_group_label>cryopreservation technique</arm_group_label>
    <arm_group_label>vitrification cryopreservation technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients (with female age &lt; 40 years)

          -  Patients undergoing a 1st oocyte retrieval for an IVF/Intracytoplasmatic Sperm
             Injection (ICSI) treatment

          -  Patients planned for an embryo transfer on day 3.

          -  Patients with supernumerary embryos of sufficient quality for freezing/vitrifying on
             day 3.

          -  Fresh personal (own oocytes)

          -  One inclusion in the study per patient.

        Exclusion Criteria:

          -  Patients undergoing a 2nd or higher ranked  oocyte retrieval after a fresh cycle with
             failed pregnancy.

          -  Female age â‰¥ 40 year

          -  Patients with Preimplantation Genetic Diagnosis (PGD)

          -  Patients with donor oocytes

          -  Patients with positive serology whose embryos may not be frozen.

          -  Patients planned for a transfer on day 2 or day 5.

          -  Patients receiving assisted hatching in the embryo transfer in the frozen cycles.

          -  Patients who have been included in the study before.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Thomas D'Hooghe, Prof. Dr</last_name>
    <phone>00 32 16 34 42 89</phone>
    <email>thomas.dhooghe@uzleuven.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Leuven University Fertility Center</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Thomas D'Hooghe</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sophie Debrock, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 11, 2013</lastchanged_date>
  <firstreceived_date>December 11, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Katholieke Universiteit Leuven</investigator_affiliation>
    <investigator_full_name>Sophie Debrock</investigator_full_name>
    <investigator_title>clinical embryologist PhD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
